Clinical Trials Directory

Trials / Completed

CompletedNCT03898440

Fetal Ano-genital Distance in 2D Ultrasound.

Using Anogenital Distance to Determinate Fetal Gender Beetween 18 et 41 Weeks of Gestation.

Status
Completed
Phase
Study type
Observational
Enrollment
318 (actual)
Sponsor
University Hospital, Brest · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine a threshold value of fetal anogenital distance in 2D ultrasound to differentiate male fetuses from female fetuses, starting 18 weeks of gestation and until the due date. The study also evaluates the feasibility of the measure and its interobserver variability.

Detailed description

The anogenital distance of female newborns is shorter than that of male newborns. Urogenital disorders, such as hypospadias and micro-penis, are associated with a shorter anogenital distance. Anogenital distance is a good marker of fetal exposure to androgenic substances. Prenatal anogenital distance ultrasound measure can help the diagnosis in case of doubt about fetal sexual phenotype or in case of urogenital disorder suspicion (hypospadias or micropenis). Is the anogenital distance easy to make measure? Can this procedure be reproduced? What are the threshold values to determine fetal sex at each term of pregnancy?

Conditions

Timeline

Start date
2019-04-15
Primary completion
2021-09-04
Completion
2021-09-04
First posted
2019-04-02
Last updated
2022-01-13

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03898440. Inclusion in this directory is not an endorsement.

Fetal Ano-genital Distance in 2D Ultrasound. (NCT03898440) · Clinical Trials Directory